News Release | U.S. PIRG | Food

House Narrowly Rejects Modest Bipartisan Measure to Limit Subsidies for Largest Agribusinesses

U.S. PIRG opposes the House Farm Bill (H.R. 1947). Like the Senate’s proposed Farm Bill, this legislation would keep the gravy train flowing for big agribusiness, locking in their unjustified corporate handouts for the next five years. The House rejected even modest amendments to reduce subsidies for the most profitable agribusinesses. The Kind-Petri amendment, which would have cut off certain subsidies for agribusinesses with high incomes, failed with a narrow 208-217 vote. 

News Release | U.S. PIRG | Food

House Rejects Farm Bill Loaded with Subsidies to Big Agribusiness

The failure of this Farm Bill is a wake-up call: The House now has the chance to make serious changes to this legislation. Our elected leaders should stand up for taxpayers, not Big Ag, by ending wasteful subsidies once and for all.

News Release | U.S. PIRG | Food

Unlikely Allies Voice Opposition to House Farm Bill

U.S. PIRG joined with taxpayer and environmental groups from across the political spectrum to voice shared opposition to much of the Farm Bill being considered by the House of Representatives. The Farm Bill passed by the U.S. Senate is nothing more than a giant handout to the largest, most profitable corporate agribusinesses. And Big Ag does even better under the current House bill.

News Release | U.S. PIRG | Health Care

Big Pharma's Pay-for-Delay Deals Take a Hit

Big Pharma's controversial "pay-for-delay" agreements took a hit today. In FTC v. Actavis, the U.S. Supreme Court ruled that the Federal Trade Commission (FTC) case against the payoff keeping generic AndroGel from the market can move ahead in the lower courts. The court chose not to declare all such payoffs unlawful, however, spurring consumer advocates to call on Congress to finish the job. 

News Release | U.S. PIRG | Food

Senate Farm Bill Continues Giant Giveaways to Big Agribusiness

The farm bill, just passed by the Senate, would keep the gravy train flowing for big agribusiness, locking in their unjustified corporate handouts for the next five years. The House needs to make serious changes to this legislation or reject it entirely.

Report | U.S. PIRG | Higher Ed

Student Loan Debt in Maine

Without a new plan from Congress, on July 1 the interest rate on subsidized Stafford student loans will double, from 3.4 percent to 6.8 percent. In Maine, 33,883 federal student loan borrowers will be impacted if the rate doubles.

News Release | U.S. PIRG | Higher Ed

Interest Rates for 33,833 Student Loan Borrowers in Maine Set to Double on July 1

According to an issue brief released today by U.S. PIRG, the upcoming increase in student loan interest rates would hike the cost of Maine students’ loans by $31 million. That translates into a $910 increase in debt per student, per loan.

(Updated 15 June 2013) U.S. officials have begun discussing a new Transatlantic Trade and Investment Partnership with Europe. The deal poses a serious threat to strong U.S food safety laws, new U.S. rules designed to prevent another bank-induced economic collapse and many other public protections. The threat will be lessened if the U.S. reverses its plan to conduct negotiations in the full view of some 600 industry "advisors" but secretly from the rest of us.

Report | U.S. PIRG | Public Health, Health Care

Prescription for Danger

Compounding pharmacies are increasingly behaving like pharmaceutical companies by producing drugs in bulk, despite the fact that they are not inspected or regulated like the pharmaceutical industry. Due to this lack of oversight, many compounding pharmacies have not adhered to safe manufacturing practices, and shown little regard for consumer safety. According to an analysis of warning letters sent to other compounding pharmacies by the FDA from 2002 to 2012, there is a long history of violations that have in many cases led to unnecessary illness, injury, and even death.

News Release | U.S. PIRG | Public Health, Health Care

New Report Documents a Decade of Safety Violations by Compounding Pharmacies

The contaminated drug that caused last fall's fungal meningitis outbreak and killed 55 people is just the tip of the iceberg of an industry-wide problem, according to a new U.S. PIRG report. The meningitis outbreak was simply the latest and deadliest in a long line of errors and risky practices by compounding pharmacies.


Join Our Call

Tell your representative to stand up for our democracy, and amplify the voices of small donors in our elections.

Support Us

Your donation supports U.S. PIRG’s work to stand up for consumers on the issues that matter, especially when powerful interests are blocking progress.

Consumer Alerts

Join our network and stay up to date on our campaigns, get important consumer updates and take action on critical issues.
Optional Member Code